Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASSUAGE: Aminophylline for Regadenoson Side Effects
NCT01250496Phase 4Terminated
- Sponsor
- Rush University Medical Center
- Start
- Nov 2010
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aminophylline in adverse drug reaction (ADR), sponsored by Rush University Medical Center. Started Nov 2010; status: terminated.
02
Drugs
aminophylline
03
Conditions
adverse drug reaction (ADR)
Beyond the preview
Go deeper on NCT01250496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01250496.